Rankings
▼
Calendar
PRTA Q2 2022 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$549M
Q2 2022 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
-97.8% YoY
Gross Profit
-$30M
-2306.2% margin
Operating Income
-$43M
-3293.4% margin
Net Income
-$41M
-3143.6% margin
EPS (Diluted)
$-0.88
QoQ Revenue Growth
+13.8%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$550M
Total Liabilities
$142M
Stockholders' Equity
$407M
Cash & Equivalents
$509M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$60M
-97.8%
Gross Profit
-$30M
$39M
-177.6%
Operating Income
-$43M
$28M
-254.6%
Net Income
-$41M
$28M
-249.2%
Revenue Segments
US Rights and Global Rights
$85M
78%
Collaboration Revenue, US Development Services
$23M
21%
Collaboration
$1M
1%
← FY 2022
All Quarters
Q3 2022 →